Related Experiment Video
Updated: Dec 27, 2025

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
Clinical conundrum: status epilepticus culminating into acute dystonia myoclonus
Madhuri Laxman Khilari1, Praveen Kumar Sharma2
1Neurology, Apollo Hospitals, Hyderabad, Telangana, India.
Insights
A child with epilepsy experienced prolonged seizures, leading to unresponsive status and later dystonia. Diagnosis revealed an atypical presentation of subacute sclerosing panencephalitis (SSPE), highlighting the need to recognize varied SSPE symptoms.
Area of Science:
- Neurology
- Pediatrics
- Infectious Diseases
Background:
- Epilepsy management in children requires careful consideration of underlying causes and potential complications.
- Perinatal hypoxia can lead to symptomatic focal epilepsy, posing long-term challenges.
Observation:
- A 7-year-old presented with prolonged status epilepticus after a history of focal epilepsy.
- Following seizure control, the child developed unresponsive status, acute dystonia, and myoclonic jerks.
- Initial differential diagnoses included hypoxic encephalopathy and encephalitis.
Findings:
- The patient was diagnosed with atypical fulminant subacute sclerosing panencephalitis (SSPE).
- Acute onset dystonia and periodic myoclonic jerks were key indicators differentiating SSPE from other conditions.
- This case highlights the importance of recognizing atypical SSPE presentations.
Implications:
- Early and accurate diagnosis of SSPE is crucial for appropriate management and prognostication.
- Clinicians should consider SSPE in pediatric cases with unusual neurological deterioration, even with a history of epilepsy.
- Understanding atypical SSPE manifestations can improve patient outcomes.
Abstract:
A 7-year-old child who suffered from symptomatic focal epilepsy as a sequel to perinatal hypoxia used to have frequent seizures. This time she developed prolonged status epilepticus lasting for over 5 hours. She received a treatment in the form of intravenous midazolam and reinitiation of sodium valproate and clobazam that were discontinued previously. Seizures were controlled over a couple of hours, but she remained unresponsive. Later, she developed acute onset dystonia (day 3 post-status epilepticus) and also myoclonic jerks. She presented to us after 3 weeks of onset of these complaints and we considered hypoxic encephalopathy resulting from prolonged status epilepticus or acute encephalitis or non-convulsive status epilepticus. However, acute onset dystonia and periodicity of myoclonic jerks were pointers against it, and on evaluation, she was diagnosed with atypical fulminant subacute sclerosing panencephalitis (SSPE). Knowing the atypical presentations of SSPE is important in planning management and prognostication.
More Related Videos
06:58Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Skeletal Muscle Relaxants: Therapeutic Uses